Literature DB >> 15564722

Treatment of SLE with anti-CD20 monoclonal antibody.

R John Looney1, Jennifer Anolik, Iñaki Sanz.   

Abstract

Systemic lupus erythemaotsus (SLE) is an autoimmune disease involving multiple organ systems and characterized by anti-nuclear antibodies. While T cells and dendritic cells may play major roles in SLE, several lines of evidence strongly suggest a central role for B cells. This article will review the role of B cells in human SLE as well as the currently available data on the treatment of SLE by depleting B cells with anti-CD20 (rituximab).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15564722     DOI: 10.1159/000082104

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  7 in total

1.  Rituximab: a review of dermatological applications.

Authors:  Jason J Emer; Wolinsky Claire
Journal:  J Clin Aesthet Dermatol       Date:  2009-05

Review 2.  Update on rituximab.

Authors:  R Eisenberg
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

3.  Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.

Authors:  Achille Aouba; Christian Pagnoux; Boris Bienvenu; Alfred Mahr; Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2007-09-12       Impact factor: 8.667

Review 4.  B-cell-targeted therapies in systemic lupus erythematosus.

Authors:  Vera Sau-Fong Chan; Helen Hoi-Lun Tsang; Rachel Chun-Yee Tam; Liwei Lu; Chak-Sing Lau
Journal:  Cell Mol Immunol       Date:  2013-01-28       Impact factor: 11.530

Review 5.  CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.

Authors:  Elvira Favoino; Marcella Prete; Andrea Marzullo; Enrico Millo; Yehuda Shoenfeld; Federico Perosa
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

6.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

7.  Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice.

Authors:  Daisuke Kawabata; Jeganathan Venkatesh; Meera Ramanujam; Anne Davidson; Christine M Grimaldi; Betty Diamond
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.